VXM01 phase I study in patients with resectable progression of a glioblastoma.

Wolfgang Wick(German Cancer Research Center), Michael Platten(German Cancer Research Center), Marlene Arzt(Heidelberg University), Martin Bendszus(Heidelberg University), David Bonekamp(Heidelberg University), Sébastien Wieckowski(Centre National de la Recherche Scientifique), Christel Herold‐Mende, Heinz Lubenau(Technische Hochschule Mannheim), Philipp Kickingereder(University of Bonn), Dennis Riehl(Johannes Gutenberg University Mainz), Antje Wick(Heidelberg University), Andreas von Deimling(German Cancer Research Center), Felix Sahm(German Cancer Research Center), Philipp Beckhove(German Cancer Research Center), Christine Jungk, Andreas Unterberg(Heidelberg University), Friedrich H. Schmitz-Winnenthal(Klinikum Aschaffenburg), Martha Nowosielski(Innsbruck Medical University)
Journal of Clinical Oncology
May 20, 2017
Cited by 4


Related Papers